» Yohana Sebhat | Yohana Sebhat :             Clinical Research Operations Manager

Yohana Sebhat

Clinical Research Operations Manager

Yohana brings an exceptional 14-year track record of advancing clinical research, healthcare administration, and public policy. Joining ONCOtherapeutics in 2023, Yohana initially contributed to clinical research at Berenson Cancer Center before transitioning exclusively on ONCOtherapeutics in 2024. Her extensive expertise spans from site-level operations to managing operations at the CRO, demonstrating a comprehensive command of the clinical research landscape.

Yohana’s academic journey is marked by a Bachelor’s in Medical Sciences with minors in Global Health Research and Public Policy (Arizona State University) complemented by international research experiences in London focusing on Urban Environmental Health and Global Health Studies. She further honed her skills with a Master’s in Public Health (University of Arizona) emphasizing Epidemiological Research and Public Administration and Policy Management, while concurrently contributing to a Neurological Research Institute in Scottsdale, AZ (Barrow Brain and Spine).

Her therapeutic areas of expertise encompass a broad-spectrum including Oncology/Hematology, Endocrinology, Dermatology, Ophthalmology, Neurology, Pediatrics, Orthopedics, Allergy, Pulmonary, COVID research, OBGYN, and Otolaryngology.

Yohana’s dedication to advancing global research is fueled by a profound commitment to revolutionizing patient care through cutting-edge protocols and new clinical research opportunities. Her work exemplifies her conviction to the transformative potential of clinical research, with a keen focus on adhering to stringent protocol and regulatory standards. Yohana excels in refining processes and developing comprehensive Standard Operating Procedures to ensure the highest levels of compliance and operational excellence are performed by ONCOtherapeutics and its study sites. Her leadership in clinical research is marked by an unwavering pursuit of innovation combined with top level trial performance, aiming to drive impactful advancements and elevate the standards of study execution.